

Is Kerendia in shortage in 2026? Get the latest update on Kerendia (Finerenone) availability, pricing, and what patients can do to find it in stock.
If you take Kerendia (Finerenone) for chronic kidney disease or heart failure, you may have heard concerns about a potential shortage — or experienced difficulty getting your prescription filled. In this article, we'll give you the latest update on Kerendia availability in 2026 and explain what's really going on.
As of early 2026, Kerendia is not listed on the FDA Drug Shortage database. This means there is no official national shortage of Finerenone. Bayer, the sole manufacturer, continues to produce and distribute Kerendia across the United States.
However, that doesn't mean you'll find it at every pharmacy. Many patients report difficulty locating Kerendia at their local pharmacy, and that experience can feel a lot like a shortage — even when the drug is technically available through the supply chain.
Even without a formal shortage, several factors make Kerendia harder to find than more common medications:
Kerendia is a brand-name medication with no generic equivalent. There is only one manufacturer (Bayer), which means there's no competition to increase supply. Pharmacies stock medications based on local demand, and many simply don't carry Kerendia regularly because they don't fill enough prescriptions for it.
At $670 to $950 for a 30-day supply without insurance, Kerendia is an expensive medication for pharmacies to keep in inventory. Smaller pharmacies, in particular, may be reluctant to stock a costly drug that might sit on the shelf for weeks.
Most insurance plans require prior authorization before covering Kerendia. This process can take days or even weeks, and during that time, the pharmacy may not order the medication until approval comes through. This creates the impression of a shortage when it's really an insurance bottleneck.
Since its approval in 2021, Kerendia has gained recognition among nephrologists, cardiologists, and endocrinologists. As more providers prescribe it — especially after its expanded indication for heart failure — demand has increased. Not all pharmacies have adjusted their ordering to match this growth.
For a deeper explanation, read our article on why Kerendia is so hard to find.
The cost of Kerendia without insurance ranges from approximately $670 to $950 for 30 tablets (a one-month supply), depending on the pharmacy and dosage. With insurance, your copay will vary depending on your plan:
For all the details on saving money, check out our complete guide: How to Save Money on Kerendia in 2026.
While there is still no generic version of Finerenone (the patent is expected to expire around 2029), there are some developments worth noting:
Here are the best strategies for locating Kerendia in 2026:
For a complete walkthrough, read how to find Kerendia in stock near you.
Kerendia is not in a formal shortage in 2026, but the combination of being a high-cost, single-source brand-name drug means that finding it at your local pharmacy can still be a challenge. The key is to plan ahead, use tools like Medfinder, and work with your doctor and pharmacist to ensure you don't miss doses.
If you're new to Kerendia, learn more about it in our comprehensive guide: What Is Kerendia? Uses, Dosage, and What You Need to Know. And if side effects are a concern, read our article on Kerendia side effects.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.